Transforming Epidemiology for 21st Century Medicine and Public Health

In 2012, the National Cancer Institute (NCI) engaged the scientific community to provide a vision for cancer epidemiology in the 21st century. Eight overarching thematic recommendations, with proposed corresponding actions for consideration by funding agencies, professional societies, and the research community emerged from the collective intellectual discourse. The themes are (i) extending the reach of epidemiology beyond discovery and etiologic research to include multilevel analysis, intervention evaluation, implementation, and outcomes research; (ii) transforming the practice of epidemiology by moving toward more access and sharing of protocols, data, metadata, and specimens to foster collaboration, to ensure reproducibility and replication, and accelerate translation; (iii) expanding cohort studies to collect exposure, clinical, and other information across the life course and examining multiple health-related endpoints; (iv) developing and validating reliable methods and technologies to quantify exposures and outcomes on a massive scale, and to assess concomitantly the role of multiple factors in complex diseases; (v) integrating “big data” science into the practice of epidemiology; (vi) expanding knowledge integration to drive research, policy, and practice; (vii) transforming training of 21st century epidemiologists to address interdisciplinary and translational research; and (viii) optimizing the use of resources and infrastructure for epidemiologic studies. These recommendations can transform cancer epidemiology and the field of epidemiology, in general, by enhancing transparency, interdisciplinary collaboration, and strategic applications of new technologies. They should lay a strong scientific foundation for accelerated translation of scientific discoveries into individual and population health benefits. Cancer Epidemiol Biomarkers Prev; 22(4); 508–16. ©2013 AACR.

[1]  S. Thacker,et al.  Epidemiology in the 21st century: calculation, communication, and intervention. , 1999, American journal of public health.

[2]  尚弘 島影 National Institute of Standards and Technologyにおける超伝導研究及び生活 , 2001 .

[3]  Anders Liljas,et al.  The Basics of Translation , 2004 .

[4]  J. Ioannidis Why Most Published Research Findings Are False , 2005, PLoS medicine.

[5]  R. Hiatt Epidemiology: key to translational, team, and transdisciplinary science. , 2008, Annals of epidemiology.

[6]  Allan Best,et al.  Knowledge integration: conceptualizing communications in cancer control systems. , 2008, Patient education and counseling.

[7]  J. Ioannidis,et al.  Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias , 2008, PloS one.

[8]  Kara L Hall,et al.  Moving the science of team science forward: collaboration and creativity. , 2008, American journal of preventive medicine.

[9]  klaguia Prepublication Data Sharing , 2009 .

[10]  Epidemiology: a problem-solving journey. , 2008, American journal of epidemiology.

[11]  B. Dunn,et al.  Landmarks in the history of cancer epidemiology. , 2009, Cancer research.

[12]  Francis S Collins,et al.  Why data-sharing policies matter , 2009, Proceedings of the National Academy of Sciences.

[13]  John P. A. Ioannidis,et al.  The Emergence of Translational Epidemiology: From Scientific Discovery to Population Health Impact , 2010, American journal of epidemiology.

[14]  Sandro Galea,et al.  Causal thinking and complex system approaches in epidemiology. , 2010, International journal of epidemiology.

[15]  Stephen M Rappaport,et al.  Environment and Disease Risks , 2010, Science.

[16]  Stephen M Rappaport,et al.  Environment and Disease Risks , 2010, Science.

[17]  Hans Hillege,et al.  Quality, quantity and harmony: the DataSHaPER approach to integrating data across bioclinical studies , 2010, International journal of epidemiology.

[18]  J. Kleinjans,et al.  Moving Forward in Human Cancer Risk Assessment , 2010, Environmental health perspectives.

[19]  J. Ioannidis,et al.  Public Availability of Published Research Data in High-Impact Journals , 2011, PloS one.

[20]  C. Tenopir,et al.  Data Sharing by Scientists: Practices and Perceptions , 2011, PloS one.

[21]  John P A Ioannidis,et al.  Improving Validation Practices in “Omics” Research , 2011, Science.

[22]  Richard Platt,et al.  Collaborations in Population-Based Health Research , 2011, Clinical Medicine & Research.

[23]  J. Dillner,et al.  Cervical cytology biobanks as a resource for molecular epidemiology. , 2011, Methods in molecular biology.

[24]  David Fenstermacher,et al.  Implementing personalized medicine in a cancer center. , 2011, Cancer journal.

[25]  R. Ness,et al.  Tools for innovative thinking in epidemiology. , 2012, American journal of epidemiology.

[26]  John P A Ioannidis,et al.  Knowledge Integration in Cancer: Current Landscape and Future Prospects , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[27]  Mukesh Verma,et al.  Opportunities and Challenges for Selected Emerging Technologies in Cancer Epidemiology: Mitochondrial, Epigenomic, Metabolomic, and Telomerase Profiling , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[28]  E. Gillanders,et al.  Frontiers in Cancer Epidemiology: A Challenge to the Research Community from the Epidemiology and Genomics Research Program at the National Cancer Institute , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[29]  Jean Marie R Pechette,et al.  Transforming health care through cloud computing. , 2012, Health care law monthly.

[30]  David J Hunter,et al.  Lessons from genome-wide association studies for epidemiology. , 2012, Epidemiology.

[31]  J. Ioannidis The importance of potential studies that have not existed and registration of observational data sets. , 2012, JAMA.

[32]  T. Sellers,et al.  Integrative cancer epidemiology--the next generation. , 2012, Cancer discovery.

[33]  David Cox,et al.  Toward a roadmap in global biobanking for health , 2012, European Journal of Human Genetics.

[34]  Tim Peakman,et al.  New Models for Large Prospective Studies: Is There a Better Way? , 2012, American journal of epidemiology.

[35]  Steven J. M. Jones,et al.  Comprehensive genomic characterization of squamous cell lung cancers , 2012, Nature.

[36]  J. Mervis U.S. science policy. Agencies rally to tackle big data. , 2012, Science.

[37]  R. Collins What makes UK Biobank special? , 2012, The Lancet.

[38]  J. Kaye The tension between data sharing and the protection of privacy in genomics research. , 2012, Annual review of genomics and human genetics (Print).

[39]  R. Haring,et al.  Diving through the "-omics": the case for deep phenotyping and systems epidemiology. , 2012, Omics : a journal of integrative biology.

[40]  Michael S. Lauer,et al.  Time for a creative transformation of epidemiology in the United States. , 2012, JAMA.

[41]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumors , 2012, Nature.

[42]  Searches of hospital patients, their rooms and belongings. , 2012, Health care law monthly.

[43]  E. Birney The making of ENCODE: Lessons for big-data projects , 2012, Nature.

[44]  Shannon M. Lynch,et al.  Bridging the Gap between Biologic, Individual, and Macroenvironmental Factors in Cancer: A Multilevel Approach , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[45]  M. Khoury,et al.  “Drivers” of Translational Cancer Epidemiology in the 21st Century: Needs and Opportunities , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[46]  M. Khoury,et al.  Provocative Questions in Cancer Epidemiology in a Time of Scientific Innovation and Budgetary Constraints , 2013, Cancer Epidemiology, Biomarkers and Prevention.

[47]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumours , 2013 .

[48]  Prabhat Jha,et al.  21st-century hazards of smoking and benefits of cessation in the United States. , 2013, The New England journal of medicine.

[49]  Lewis H Kuller,et al.  Point: is there a future for innovative epidemiology? , 2013, American journal of epidemiology.

[50]  D. Ransohoff Cultivating Cohort Studies for Observational Translational Research , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[51]  C. Ulrich,et al.  Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational research. , 2013, Journal of the National Cancer Institute.